Longeveron Inc. (LGVN)

NASDAQ: LGVN · Real-Time Price · USD

0.9289

+0.0119 (1.30%)

At close: Oct 28, 2025, 4:00 PM EDT

0.9250

-0.0039 (-0.42%)

Pre-market: Oct 29, 2025, 7:44 AM EDT

Longeveron Employees

Longeveron had 25 employees as of December 31, 2024. The number of employees increased by 1 or 4.17% compared to the previous year.

Employees

25

Change (1Y)

1

Growth (1Y)

4.17%

Revenue / Employee

$82,920

Profits / Employee

-$747,600

Market Cap

19.56M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	25	1	4.17%
Dec 31, 2023	24	3	14.29%
Dec 31, 2022	21	1	5.00%
Dec 31, 2021	20	8	66.67%
Dec 31, 2020	12	-4	-25.00%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

LGVN News

1 day ago - Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect - GlobeNewsWire
22 days ago - Longeveron® to Participate in the 4th Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
5 weeks ago - Longeveron® to Attend Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa - GlobeNewsWire
7 weeks ago - Longeveron® Announces Key Leadership Updates - GlobeNewsWire
2 months ago - Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
2 months ago - Longeveron Inc. (LGVN) Q2 2025 Earnings Call Transcript - Seeking Alpha
2 months ago - Longeveron® Announces Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
2 months ago - Longeveron Announces Closing Of Up To $17.5 Million Public Offering - GlobeNewsWire